217 related articles for article (PubMed ID: 25043077)
21. Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I.
Snarski E; Milczarczyk A; Torosian T; Paluszewska M; Urbanowska E; Król M; Boguradzki P; Jedynasty K; Franek E; Wiktor-Jedrzejczak W
Bone Marrow Transplant; 2011 Apr; 46(4):562-6. PubMed ID: 20581881
[TBL] [Abstract][Full Text] [Related]
22. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
[TBL] [Abstract][Full Text] [Related]
23. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
[TBL] [Abstract][Full Text] [Related]
25. Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.
Zhang X; Ye L; Hu J; Tang W; Liu R; Yang M; Hong J; Wang W; Ning G; Gu W
PLoS One; 2012; 7(2):e31887. PubMed ID: 22384093
[TBL] [Abstract][Full Text] [Related]
26. Delayed diagnosis and issues with pump usage are the leading causes of diabetic ketoacidosis in children with diabetes living in Newfoundland and Labrador, Canada.
Jackman J; Chafe R; Albrechtsons D; Porter R; Nugent C; Waheed S; Newhook LA
BMC Res Notes; 2015 Apr; 8():158. PubMed ID: 25889476
[TBL] [Abstract][Full Text] [Related]
27. Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.
Walicka M; Milczarczyk A; Snarski E; Jedynasty K; Halaburda K; Torosian T; Urbanowska E; Król M; Jędrzejczak WW; Franek E
Diabetes Res Clin Pract; 2018 Sep; 143():357-363. PubMed ID: 30036612
[TBL] [Abstract][Full Text] [Related]
28. Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes.
Gu W; Hu J; Wang W; Li L; Tang W; Sun S; Cui W; Ye L; Zhang Y; Hong J; Zhu D; Ning G
Diabetes Care; 2012 Jul; 35(7):1413-9. PubMed ID: 22723579
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus.
Xiang H; Chen H; Li F; Liu J; Su Y; Hao L; Wang F; Wang Z; Zeng Q
Cytotherapy; 2015 Nov; 17(11):1638-45. PubMed ID: 26318272
[TBL] [Abstract][Full Text] [Related]
30. Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes?
Low JC; Felner EI; Muir AB; Brown M; Dorcelet M; Peng L; Umpierrez GE
Prim Care Diabetes; 2012 Apr; 6(1):61-5. PubMed ID: 22230097
[TBL] [Abstract][Full Text] [Related]
31. Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.
Xiang H; Yang C; Xiang T; Wang Z; Ge X; Li F; Su Y; Chen H; Huang X; Zeng Q
Stem Cells Transl Med; 2016 May; 5(5):651-7. PubMed ID: 27025691
[TBL] [Abstract][Full Text] [Related]
32. An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes.
Snarski E; Szmurło D; Hałaburda K; Król M; Urbanowska E; Milczarczyk A; Franek E; Wiktor-Jedrzejczak W
Acta Diabetol; 2015 Oct; 52(5):881-8. PubMed ID: 25744552
[TBL] [Abstract][Full Text] [Related]
33. Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?
Carulli E; Pompilio G; Vinci MC
Cells; 2023 Mar; 12(7):. PubMed ID: 37048127
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.
Cantú-Rodríguez OG; Lavalle-González F; Herrera-Rojas MÁ; Jaime-Pérez JC; Hawing-Zárate JÁ; Gutiérrez-Aguirre CH; Mancias-Guerra C; González-Llano O; Zapata-Garrido A; Villarreal-Pérez JZ; Gómez-Almaguer D
J Clin Endocrinol Metab; 2016 May; 101(5):2141-8. PubMed ID: 26859103
[TBL] [Abstract][Full Text] [Related]
35. Perioperative management with prolonged intravenous insulin infusion versus subcutaneous insulin in children with type I diabetes mellitus.
Kaufman FR; Devgan S; Roe TF; Costin G
J Diabetes Complications; 1996; 10(1):6-11. PubMed ID: 8639976
[TBL] [Abstract][Full Text] [Related]
36. Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
Steck AK; Larsson HE; Liu X; Veijola R; Toppari J; Hagopian WA; Haller MJ; Ahmed S; Akolkar B; Lernmark Å; Rewers MJ; Krischer JP;
Pediatr Diabetes; 2017 Dec; 18(8):794-802. PubMed ID: 28127835
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
Crinò A; Schiaffini R; Manfrini S; Mesturino C; Visalli N; Beretta Anguissola G; Suraci C; Pitocco D; Spera S; Corbi S; Matteoli MC; Patera IP; Manca Bitti ML; Bizzarri C; Pozzilli P;
Eur J Endocrinol; 2004 May; 150(5):719-24. PubMed ID: 15132730
[TBL] [Abstract][Full Text] [Related]
38. Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.
Li L; Shen S; Ouyang J; Hu Y; Hu L; Cui W; Zhang N; Zhuge YZ; Chen B; Xu J; Zhu D
J Clin Endocrinol Metab; 2012 May; 97(5):1729-36. PubMed ID: 22419704
[TBL] [Abstract][Full Text] [Related]
39. Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy.
von Laer Tschudin L; Schwitzgebel VM; von Scheven-Gête A; Blouin JL; Hofer M; Hauschild M; Ansari M; Stoppa-Vaucher S; Phan-Hug F
Pediatr Diabetes; 2015 Mar; 16(2):138-45. PubMed ID: 24552605
[TBL] [Abstract][Full Text] [Related]
40. Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus.
Tornese G; Tisato V; Monasta L; Vecchi Brumatti L; Zauli G; Secchiero P
Acta Diabetol; 2015 Oct; 52(5):1003-6. PubMed ID: 25863780
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
